Barosense
Signal active
Organization
Contact Information
Overview
BaroSense is committed to develop and commercialize novel anti-obesity products that provide a meaningful contribution to this leading healthcare problem facing the United States today. BaroSense was conceived in order to create a safe, simple, effective, and minimally invasive alternative to the surgical treatment of obesity - an innovative approach to assist those people who need help beyond traditional diets, and who wish to avoid extensive, irreversible surgery.
About
Industries
Biotechnology, Health Care, Medical Device, Therapeutics
Founded
2001
Employees
11-50
Headquarters locations
United States, North America
Social
N/A
Profile Resume
Barosense headquartered in United States, North America, operates in the Biotechnology, Health Care, Medical Device, Therapeutics sector. The company focuses on Biotechnology and has secured $3.2B in funding across 64 round(s). With a team of 11-50 employees, Barosense is actively contributing to advancements in Biotechnology. Their latest funding round, Series D - Barosense, raised $27.0M. Discover more about their projects, partnerships, and impact on our platform.
Employees
N/A
Funding Rounds
Funding rounds
4
Investors
8
Lead Investors
0
Total Funding Amount
$50.6M
Details
4
Barosense has raised a total of $50.6M in funding over 4 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2007 | Late Stage Venture | 11.2M | ||
| 2004 | Early Stage Venture | 6.2M | ||
| 2002 | Early Stage Venture | 6.2M | ||
| 2009 | Late Stage Venture | 27.0M |
Investors
Barosense is funded by 21 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Frazier Healthcare Partners | - | FUNDING ROUND - Frazier Healthcare Partners | 6.2M |
| David L. Douglass | - | FUNDING ROUND - David L. Douglass | 6.2M |
| Barosense | - | FUNDING ROUND - Barosense | 6.2M |
| Delphi Ventures | - | FUNDING ROUND - Delphi Ventures | 6.2M |
Recent Activity
There is no recent news or activity for this profile.